©iStockphoto.com/heidijpix
©iStockphoto.com/heidijpix
by Amy Spangler
October 11, 2007
Major producers of over-the-counter cough and cold medicines announced today that they were voluntarily withdrawing their products from the market for fear that they could be misused by parents. The voluntary withdrawal affects only products labeled for use in infants and children under 2 years of age.
The action comes two weeks after reviewers within the Food and Drug Administration (FDA) urged the agency to consider an outright ban of over-the-counter cough and cold products for children under the age of 6 years—a move previously recommended by the industry’s own trade association, the Consumer Healthcare Products Association (CHPA).
A Non-prescription Drugs Advisory Committee will meet October 18–19 to further examine the safety and effectiveness of cough and cold medicines in children, and offer recommendations to the FDA.
There are roughly 800 over-the-counter pediatric cough and cold medicines. The CHPA maintain that the medicines are safe and effective when used as directed.
U.S. Food and Drug Administration reviewers have said that from 1969 through 2006 the agency received 54 reports of deaths with decongestants and 69 with antihistamines. Most were in children younger than 2 years of age. Overdose and drug toxicity were commonly reported in those cases, they said. Many of these children died after their parents mistakenly gave them too much medicine, either because they did not realize that products from two different manufacturers contained the same ingredient, or the parents measured doses incorrectly. But there are growing reports that even children given recommended quantities of the medicines may be at risk.
The Poison Control Center of the Children’s Hospital of Philadelphia recently reported on four cases of prolonged hallucinations in children as old as 6 years who were given recommended doses of the medicines. With almost no evidence that they are effective and growing worries that they may be unsafe, a group of prominent pediatricians petitioned the agency earlier this year to consider banning the drugs’ use in young children.
Among the products being withdrawn are Dimetapp Decongestant Infant Drops, Little Colds Decongestant Plus Cough, Pediacare Infant Drops Decongestant, Robitussin Infant Cough DM Drops, Triaminic Infant and Toddler Thin Strips Decongestant, and Tylenol Concentrated Infant Drops Plus Cold and Cough. A complete listing can be found on the CHPA website.
Avoiding drug overdoses
Reports of child morbidity and mortality associated with the use of these products appears to be the result of giving too much of these medicines to children. An over-the-counter cough and cold medicine can be harmful if more than the recommended amount is used, if the medicine is given too often, or if more than one cough and cold medicine containing the same active ingredient is used. To avoid overdoses, parents must carefully follow the directions for use that appear on the package label.
More tips on using cough and cold products in children:
If a child’s condition worsens or does not improve, stop using the product and immediately take the child to a health care provider for evaluation.